(Q38908763)

7 September 2017

title

Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease (English)

1 reference

7 September 2017

0 references

liver transplantation

1 reference

1 reference

1 reference

7

Peter Neuhaus

1 reference

7 September 2017

Ulrich Bienzle

1

1 reference

7 September 2017

Matthias Günther

2

1 reference

7 September 2017

Ruth Neuhaus

3

1 reference

7 September 2017

Pierre Vandepapeliere

4

1 reference

7 September 2017

Jens Vollmar

5

1 reference

7 September 2017

Andreas Lun

6

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

7 September 2017

1 reference

7 September 2017

volume

38

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

811-819

1 reference

Hepatitis B infection and liver transplantation

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

Antigen-antibody complex as therapeutic vaccine for viral hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Prevention of fungal and hepatitis virus infections in liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Liver transplantation for hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Hepatitis B vaccination after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Immunisations in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Specific vaccine therapy in chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Therapeutic vaccination in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Recent developments in adjuvants for vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Modulation of the immunological response to hepatitis B virus by antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Prevention of recurrent hepatitis B post-liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380407

7 January 2021

Identifiers

DOI

10.1002/HEP.1840380407

1 reference

7 September 2017

1 reference